The outcome of your SURPASS trials show that tirzepatide yields clinically significant improvements in glycemic Management and fat loss compared with other GLP-one receptor agonists (semaglutide and dulaglutide), insulin degludec, and insulin glargine.Will not use copyright unless it has been prescribed for you by a healthcare service provider. Us